Cell Bioprocessing

Categories

Subscribe!

Cas-CLOVER is easy to license

Feb 27 2024

Demeetra’s Guide to CRISPR and Gene Editing Licensing

Demeetra's Guide to CRISPR and Gene Editing Licensing Blog Agriculture ...

Oct 18 2022

Protein Engineered Cas-CLOVER Yields 99% Gene Editing Efficiency and Ultra-Low Toxicity

At the 2022 Bioprocessing Summit, Demeetra’s Corey Brizzee presented Cas-CLOVER’s ...

Aug 24 2022

Q&A Podcast: Advanced Alternatives to CRISPR/Cas9

The field of genetic engineering is evolving much faster than ...

Aug 9 2022

Gene Editing May Soon Be Rolling in Clover

The early CRISPR-Cas9 gene editing systems didn’t lack for brashness. ...

Jul 14 2022

The Greatest Gene Editing Technology on the Planet?

As published in GEN Magazine. Cas-CLOVER significantly reduces off-target risk ...

Mar 22 2022

Glycoengineering Strategies For Improved Biologics Manufacturing In Mammalian Cells Using Cas-CLOVER

Biopharmaceuticals, encompassing monoclonal antibodies (mAbs) and their derivatives such as ...

Mar 20 2022

Unlocking the Future of Gene Therapy, rAAV And Vaccine Bioprocessing: Advanced Cas-CLOVER Gene Editing in HEK293 Cells

Recombinant adeno-associated virus (rAAV) vectors are a prime example of ...